Journal of Developing Drugs, a peer reviewed, Open Access Journal provides an open platform for eminent scientists around the globe to publish their scholarly work in field related to Drugs. Various regulatory approaches for toxic chemicals management are included in scope of Journal of Developing Drugs.

Journal of Developing Drugs is an open access, peer reviewed international journal with a primary objective to provide research and applications related to Pharmaceutical & Toxicology Sciences.

The Journal deals with surgery, internal medicine, cardiovascular medicine, complementary medicine, dentistry and oral medicine, pathology, pharmacology and therapeutics, respiratory medicine, rheumatology, drugs and medicines, emergency medicine, infectious diseases, medical education, legal and forensic medicine and safety testing, drug legislation and safety.

We will consider manuscripts from any part of the world for publication.

Journal of Developing Drugs is using Editorial Tracking System to maintain quality and transparency to the author in the peer-review process. Review processing will be performed by the editorial board members of the Journal of Developing Drugs or by Reviewers (outside experts in the field). Two independent reviewer’s approval (Minimum reviewer’s approval) followed by editor approval is obligatory for acceptance of any manuscript excluding an editorial.

On the occasion of its 9 years, Successful Journey, Journal of Developing Drugs decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Drugs, Diseases and Medicine.

Regards

Angelina Jonas PhD

Editorial office
Journal of Developing Drugs
Submit manuscript at www.longdom.org/submissions/developing-drugs.html
E-mail: devdrugs@pharmares.org
What’s app Number: +3225889658